Merontos, Chloe Belle .

HRN: 25-92-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
AMPICILLIN 250MG (VIAL)
10/08/2024
10/15/2024
IV
210mg
Q6h
T/c Neonatal Conjunctivis
Waiting Final Action 
10/08/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
10/08/2024
10/15/2024
IV
21mg
Q24h
T/c Neonatal Conjunctivitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: